Researchers and engineers at Medtronic are working on an artificial device designed to replace diseased heart valves of patients who are not qualified to undergo open-heart surgery. Medtronic thinks the worldwide market for synthetic heart valve, which can be implanted via a patient's femoral artery using a tube-and-wire catheter tool, could reach $3.5 billion.

Related Summaries